Figure 5From: Evaluation of the efficacy of a commercial inactivated genogroup 2b-based porcine epidemic diarrhea virus (PEDV) vaccine and experimental live genogroup 1b exposure against 2b challenge PEDV RNA shedding in feces at different days post PEDV G2b challenge (dpc). Pigs were exposed to PEDV at 3 weeks of age (dpv 0) with live PEDV G1b or vaccinated at 3 (dpv 0) and 5 (dpv 14) weeks of age with a commercial inactivated PEDV G2b vaccine. Pigs were challenged with PEDV G2b at 7 weeks of age (dpv 28/dpc 0). A. Mean group log10 PEDV genomic copies per mL of fecal swab suspension ± SEM. Significant different values for a sample type and dpc are indicated by different superscripts (A,B,C). The significance level was set to P < 0.05. There were no significant differences among groups on dpv 0 and 21 and on dpc 0, 8, 11 and 13Back to article page